Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-25 @ 5:03 AM
NCT ID:
NCT00998218
Eligibility Criteria:
Inclusion Criteria:
* Implant of AICD for the prevention of sudden cardiac death Implant of AICD for the prevention of sudden cardiac death
Exclusion Criteria:
* Any anti-arrhythmic agent (other than beta-blockers)
* History of or intolerance to ranolazine during the run in.
* History of severe constipation defined as requiring laxatives more than 5 times a week in order to have a bowel movement.
* Because of a weak inhibitory effect of ranolazine of the cytochrome p450, CYP 3A4, certain drugs metabolized by that system could accumulate. Although clinically significant interactions of ranolazine with these agents has not been demonstrated, patients on maximum doses of simvastatin, or patients on verapamil or diltiazem will be excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00998218
Study Brief:
Protocol Section:
NCT00998218